Daily variability in mineral metabolites in CKD and effects of dietary calcium and calcitriol (Q35917442)

11 August 2017

Daily variability in mineral metabolites in CKD and effects of dietary calcium and calcitriol (English)

1 reference

11 August 2017

1 reference

9

Harald Jüppner

1 reference

11 August 2017

10

Myles Wolf

1 reference

11 August 2017

Tamara Isakova

1

1 reference

11 August 2017

Huiliang Xie

2

1 reference

11 August 2017

Allison Barchi-Chung

3

1 reference

11 August 2017

Kelsey Smith

4

1 reference

11 August 2017

Nicole Sowden

5

1 reference

11 August 2017

Michael Epstein

6

1 reference

11 August 2017

Gina Collerone

7

1 reference

11 August 2017

Leigh Keating

8

1 reference

11 August 2017

1 March 2012

1 reference

Clinical Journal of the American Society of Nephrology

11 August 2017

1 reference

11 August 2017

7

1 reference

11 August 2017

5

1 reference

11 August 2017

820-828

1 reference

FGF23 induces left ventricular hypertrophy

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338283

Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338283

Secondary hyperparathyroidism: pathogenesis, disease progression, and therapeutic options.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338283

Effects of dietary phosphate and calcium intake on fibroblast growth factor-23

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338283

Circulating levels of soluble klotho and FGF23 in X-linked hypophosphatemia: circadian variance, effects of treatment, and relationship to parathyroid status

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338283

KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD).

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338283

Chronic kidney disease and bone fracture: a growing concern

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338283

Association of oral calcitriol with improved survival in nondialyzed CKD.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338283

Postprandial mineral metabolism and secondary hyperparathyroidism in early CKD

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338283

Evidence for a signaling axis by which intestinal phosphate rapidly modulates renal phosphate reabsorption

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338283

Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338283

FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338283

Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338283

Calcium balance in normal individuals and in patients with chronic kidney disease on low- and high-calcium diets

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338283

Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338283

Diuretics, calciuria and secondary hyperparathyroidism in the Chronic Renal Insufficiency Cohort

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338283

Calcitriol and doxercalciferol are equivalent in controlling bone turnover, suppressing parathyroid hormone, and increasing fibroblast growth factor-23 in secondary hyperparathyroidism

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338283

Evidence that postprandial reduction of renal calcium reabsorption mediates hypercalciuria of patients with calcium nephrolithiasis.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338283

Fibroblast growth factor-23 relationship to dietary phosphate and renal phosphate handling in healthy young men.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338283

K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338283

Net intestinal absorption of calcium in patients with chronic renal failure.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338283

Evidence for secondary hyperparathyroidism in idiopathic hypercalciuria

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338283

Determinants of parathyroid hormone levels in nursing home residents

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338283

Frusemide therapy and intact parathyroid hormone plasma concentrations in chronic renal insufficiency

22 October 2018

1 reference

12 December 2020

Risk factors for secondary hyperparathyroidism in a nursing home population

1 reference

12 December 2020

The parathyroid hormone circadian rhythm is truly endogenous--a general clinical research center study

1 reference

12 December 2020

Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease

1 reference

12 December 2020

Direct evidence for a causative role of FGF23 in the abnormal renal phosphate handling and vitamin D metabolism in rats with early-stage chronic kidney disease

1 reference

12 December 2020

Identifiers

DOI

10.2215/CJN.11721111

1 reference

11 August 2017

1 reference

11 August 2017

PubMed publication ID

22383746

1 reference